Target intelligence / Profile preview

Broad immune system

Molecular classification
Other
01

Overview

The immune system is a complex, multi-layered network of cells (such as lymphocytes and phagocytes), tissues (like the spleen and thymus), and soluble factors that protect the host from pathogenic organisms and provide surveillance against neoplastic cells (Source: NIH, Overview of the Immune System). It is broadly divided into the innate immune system, providing rapid, non-specific responses, and the adaptive immune system, which generates highly specific, memory-based protection. In clinical pharmacology, the broad immune system is not considered a single therapeutic target but rather a physiological system containing thousands of distinct molecular targets, including G protein-coupled receptors, enzymes, and cytokines. Dysregulation of this system is central to the pathogenesis of numerous conditions, ranging from rheumatoid arthritis and multiple sclerosis to sepsis and various cancers (Source: StatPearls, Immune System). Therapeutic strategies involve immunomodulation, where drugs either suppress an overactive response (immunosuppressants) or enhance a deficient one (immunotherapy). Because of the system's interconnected nature, broad modulation often carries significant risks, such as severe infection or the development of lymphoma (Source: Merck Manual, Overview of the Immune System).

Other names
Immune systemHost defense systemLymphatic system
02

Mechanism of action

Not applicable as a single molecular mechanism; drugs targeting the immune system act via diverse pathways including cytokine inhibition, lymphocyte depletion, and checkpoint blockade (Source: StatPearls, Physiology, Immune Response).

03

Biological functions

Immune responseHost defenseInflammationHomeostasisImmunological memoryAntigen presentation
04

Disease associations

InfectionAutoimmune diseaseCancerInflammationImmunodeficiencyAllergyGraft-versus-host disease
05

Safety considerations

Increased susceptibility to opportunistic infectionsRisk of secondary malignanciesCytokine release syndrome (CRS)Infusion reactionsAutoimmune-related adverse events (irAEs)Bone marrow suppression
06

Interacting drugs

Cyclosporine

5 more in the full profile.

07

Biomarkers

White blood cell countC-reactive protein (CRP)Absolute neutrophil count (ANC)Cytokine profiles (e.g., IL-6, TNF-alpha)Immunoglobulin levels (IgG, IgA, IgM)

Beyond the preview

Go deeper on Broad immune system.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Broad immune system.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call